Biophytis (EPA:ALBPS)

BRIEF

published on 01/27/2025 at 07:05, 1 year ago

Biophytis to Participate in BIOMED FORUM Investor Conference

Biophytis Investor Conference Healthcare Sector Paris BIOMED Forum
REGULATED PRESS RELEASE

published on 01/27/2025 at 07:00, 1 year ago

Biophytis announces its participation to the BIOMED FORUM investor conference
Biophytis announces participation in Biomed Forum investor conference to engage with investors and share updates on developments for age-related diseases

Biophytis Investor Conference Healthcare Sector BIOMED Forum Age-related Diseases
BRIEF

published on 01/21/2025 at 07:05, 1 year ago

Biophytis and AskHelpU Form Co-Development Partnership in China

Biophytis China ALS Co-development AskHelpU
REGULATED PRESS RELEASE

published on 01/21/2025 at 07:00, 1 year ago

Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China
Biophy's and AskHelpU sign a co-development agreement for rare neuromuscular diseases in China. The agreement aims to evaluate BIO101's efficacy in ALS, potentially offering a major therapeutic solution for patients

Biophy's ALS AskHelpU Co-development Agreement Neuromuscular Diseases
BRIEF

published on 01/14/2025 at 07:05, 1 year ago

Biophytis Enters Exclusive Negotiations for BIO101 in China

Biophytis Age-related Diseases BIO101 Pharmaceutical Partnership China Licensing
REGULATED PRESS RELEASE

published on 01/14/2025 at 07:00, 1 year ago

Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101
Biophytis enters exclusive negotiations with a Chinese pharmaceutical company to license BIO101 for viral respiratory infections, sarcopenia, and obesity. The potential partnership aims to develop and commercialize the drug in China's growing pharmaceutical market

Biophytis Exclusive Negotiations Chinese Pharmaceutical Company BIO101 License Viral Respiratory Infections
BRIEF

published on 01/08/2025 at 07:05, 1 year ago

Biophytis Secures €8.6 Million for Obesity Program

Clinical Development Debt Conversion Obesity Program Biophytis Financing New Investors
REGULATED PRESS RELEASE

published on 01/08/2025 at 07:00, 1 year ago

Biophytis Announces New Cash Contribution and Debt Conversion up to €8.6 million to Finance the Obesity Program
Biophytis announces new cash contribution and debt conversion totaling €8.6 million to finance obesity program. Strategic financial transaction strengthens company's financial structure for future development

Biophytis Financial Transaction Debt Conversion Obesity Program Cash Contribution
BRIEF

published on 01/06/2025 at 08:35, 1 year ago

Biophytis Temporarily Suspends Trading of Shares Before Refinancing

Biophytis Biotechnology Refinancing Age-related Diseases Trading Suspension
REGULATED PRESS RELEASE

published on 01/06/2025 at 08:30, 1 year ago

Biophytis announces temporary suspension of the listing of its shares and share warrants prior to the completion of a refinancing transaction
Biophytis temporarily suspends listing of shares and share warrants prior to refinancing transaction. Trading to resume soon

Biophytis Shares Refinancing Listing Suspension

Published on 01/31/2026 at 03:15, 4 hours 2 minutes ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 4 hours 57 minutes ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 5 hours 37 minutes ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 7 hours 17 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 8 hours 17 minutes ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 02:45, 4 hours 32 minutes ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 9 hours 17 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 11 hours 7 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 11 hours 8 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 11 hours 10 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches

View all EQS

Published on 01/30/2026 at 17:45, 13 hours 32 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 23 hours 17 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 1 day 13 hours ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 13 hours ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 13 hours ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

News